Apria Stock News

Apria (NYSE:APR) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Valuation & Earnings This table compares Apria and Aveanna Healthcares top-line revenue, earnings per share (EPS) []

Apria (NYSE:APR) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a report issued on Wednesday, Zacks.com reports. The firm presently has a $34.00 price target on the stock. Zacks Investment Researchs target price points to a potential upside of 15.41% from the stocks previous close. According to Zacks, []

Aveanna Healthcare (NASDAQ:AVAH) and Apria (NYSE:APR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings. Earnings & Valuation This table compares Aveanna Healthcare and Aprias gross revenue, earnings per share and []

Apria, Inc. (APR) CEO Dan Starck on Q3 2021 Results - Earnings Call Transcript

INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today that it will release fiscal third quarter 2021 financial results on Thursda

Apria (APR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Apria (APR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our short

Apria (APR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our short

Apria, Inc. (APR) CEO Dan Starck on Q2 2021 Results - Earnings Call Transcript

INDIANAPOLIS, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of integrated home healthcare equipment and related services in the Uni

INDIANAPOLIS, July 22, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today that it will release fiscal second quarter 2021 financial results on Thursd

INDIANAPOLIS, June 14, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today the completion of a secondary offering of 5,175,000 shares of Apria common

INDIANAPOLIS, June 09, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today the pricing of a previously announced secondary offering of 4,500,000 share

INDIANAPOLIS, June 07, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) announced today that a selling stockholder affiliated with Blackstone has commenced a secondary offering

Apria Inc. (APR) CEO Dan Starck on Q1 2021 Results - Earnings Call Transcript